PPARD and cardiovascular disorder: GW501516 (cardarine or 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl) phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid) is a compound which belongs to the peroxisome-proliferator-activated receptor delta (PPAR-δ) agonists group [1] and was developed with the purpose of metabolic and cardiovascular disease treatment.